THE EXECUTIVE COMMITTEE HAS 9 MEMBERS
Sébastien Aguettant Chairman
Sébastien Aguettant joined Delpharm in 1996 and he is the Chairman since 2010. Previously, he was Sales Director, Plant Manager and then Delpharm Co-Chairman in 2004.
He is also active within pharmaceutical industry associations (LEEM).
Sébastien is graduated in Law from Paris-Assas University and from I.S.C
Alain Kirchmeyer CEO
Alain Kirchmeyer was appointed CEO of Delpharm in 2022.
Previously, he held operational and general management positions in various business sectors such as materials, electrical equipment or chemicals; Saint-Gobain (1991-2000), Schneider Electric (2000-2005), Hager (2005-2008), Morgan Advanced, CRH (2008-2013), Materials Plc (2014-2017) and Johnson Matthey PLC (2017-2018). Finally, he worked at Unither Pharmaceuticals as Managing Director (2019-2022).
Alain is graduated from L’Ecole des Mines from Paris.
Nicolas Ragot Chief Operating Officer
Nicolas RagotChief Operating Officer
Nicolas Ragot joined Delpharm in 2018 as Chief Operating Officer.
Previously, he started his career as a Process Engineer in Eli Lilly (1990-1993), then he integrated Prographarm as a Product Manager first and then Plant Manager (1993-2000). Finally, he joined GSK (2000-2018) and had different positions: Production Director, Plant Manager and Supply Chain Director in Europe, Middle East and Africa.
Nicolas is an Engineer graduated from the University of Technology of Compiègne and in Sciences from California University in Davis.
Stéphane Lepeu Chief Sales Officer
Stéphane LepeuChief Sales Officer
Stéphane Lepeu joined Delpharm in 2012 as Chief Sales Officer.
Stéphane is also the president of the French CDMO association (CDMO France)
Previously, he started his career working in the wholesaling sector representing Procter & Gamble (1997-2001). Finally, he worked for Alcan Packaging Beauty (currently called Albéa) as Market Manager & Europe Sales Manager. (2002-2011).
Stéphane is graduated from ESCP-Europe.
Charles Gaudin Chief Financial Officer
Charles GaudinChief Financial Officer
Charles Gaudin joined Delpharm in 2012, as Chief Financial Officer.
Previously, he started his career as Business Manager in Commercial Bank and Investment Bank in Milano, London and Paris (1993-1997), as Strategy and Organization Consulting Manager in Deloitte/Braxton Associates (1997-2001), then as Private Equity Investment Director in Natixis (2001-2005). Finally, he was CFO of Poweo (2006-2012).
Charles is graduated from ESSEC.
Olivier Lavictoire Chief Human Resources Officer
Olivier LavictoireChief Human Resources Officer
Olivier Lavictoire joined Delpharm in 2019, as Chief Human Resources Officer.
Previously, he held several positions with increasing responsibilities at GL Events (1998-2000), Wolters Kluwer (2000-2001) and Trèves (2001-2010). Finally, he was International Human Resources Director of Lectra (2010-2019).
Olivier is graduated from Institute of Preparation for Administration and Management and obtained a MBA in Human Resources Management from Paris-Dauphine University.
Pauline Lougnon General Counsel
Pauline LougnonGeneral Counsel
Pauline Lougnon joined Delpharm in 2006 as Legal Responsible and was promoted to General Counsel in 2011.
Previously, she was lawyer in Slaughter and May Office (1998-2006).
Pauline obtained a Master’s degree in private law, a Master 2 in International Business Law and a Professional Lawyer’s Certification.
Damien Brossard Chief Quality Officer
Damien BrossardChief Quality Officer
Damien Brossard joined Delpharm in 2008 as Quality Coordinator and was promoted to Chief Quality Officer after different operational responsibilities at Delpharm (Evreux, Lille, Drogenbos and Reims).
Previously, he started his career as Operational Quality Assurance Manager and Procurement and Planning Manager in Pierre Fabre (2001-2008).
Damien obtained a degree of doctor in pharmacy and a Master 2 in Total Quality and Biotechnologies from Angers University.
Jean-Bernard Dumas Chief Scientific Officer
Jean-Bernard DumasChief Scientific Officer
Jean-Bernard Dumas joined Delpharm in 2009 as Chief Scientific Officer.
Previously, he worked in different production roles such as Solid Forms Production Manager and Production, Methods and Maintenance Director in Pierre Fabre (1988-2001). Finally, he worked in Boehringer Ingelheim as Production Director and Industrial and Methods Development Director (2001-2009).
Jean-Bernard obtained a degree of doctor in pharmacy, a Master 2 in galenical industrial and a IAE-CAAE from Toulouse.